Find the latest CERo Therapeutics Holdings, Inc. (CERO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Dec 22, 2025 · CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer.

6 days ago · Get the latest CERo Therapeutics Holdings, Inc. (CERO) stock price with financials, statistics, dividends, charts and more.

Get CERo Therapeutics Holdings Inc (CERO:OTCQB) real-time stock quotes, news, price and financial information from CNBC.

4 days ago · CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its …

CERo, incorporated in Delaware on September 23, 2016, and based in South San Francisco, focuses on genetically engineering immune cells to fight cancer. Since inception, CERo has …

CERo is building a broad pipeline of CER T-cell products. Our lead program in hematologic malignancies targets an "Eat Me" signal upregulated on B cell and myeloid tumors. © 2025 …

Mar 12, 2025 · CERo Therapeutics Holdings, Inc. to Present Data at the Society for Immunotherapy of Cancer Spring Scientific March 12-14 CERo SITC Spring Scientific Poster …

Get the latest CERo Therapeutics Holdings, Inc. (CERO) stock news and headlines to help you in your trading and investing decisions.

We are advancing a CER T-cell platform that potentially offers novel approaches for the treatment of both hematologic malignancies and solid tumors. Therapeutic Potential of our Platform. © …